Welcome back to the OptimusEdge. Studies on large language models used for clinical decision support have found hallucination rates between 8% and 20%.

Sit with that for a second.

Now imagine that same model deciding, on its own, who gets seen first in an emergency room.

That's exactly why today's design thinking starts from the oversight question, not the AI question.
___________________________________________________________
The Edge Upload: Today’s Insights

The scale is bigger than most people think: the FDA had authorized more than 1,450 AI-enabled medical devices by the end of 2025. It cleared 295 in that year alone.

Oversight is loosening, not tightening: in January 2026, the FDA issued updated guidance easing requirements for tools that offer a single recommendation. The catch: a clinician still has to be able to review the logic behind it. People are already calling it the "glass box" rule.

NVIDIA is building for this directly: Nemotron, NVIDIA's open model family, names "ambient healthcare agents" and "deep clinical research agents" as target use cases. This isn't a hypothetical. It's a stated design target.

Let me think this through the way I'd actually approach it.

Not the way a finished product page describes it.

A triage agent's job sounds simple: look at symptoms and vitals, figure out urgency, get the patient to the right level of care fast.

But "figure out" is doing a lot of work in that sentence.

Underneath it is a life-or-death classification task. Made under time pressure. On incomplete information. For a patient who often can't fully describe what's wrong.

That's the real shape of the problem.

Worth sitting with it before reaching for any NVIDIA product the tech choices only make sense once the stakes are clear.

Here's how I'd start piecing this together, module by module.

The agent needs to ingest real-time signals vitals monitors, maybe a camera or wearable feed. Fast enough that a delay doesn't become part of the risk itself.

That's exactly the job Holoscan is built for.

A real-time runtime that pulls in high-bandwidth sensor data and reasons over it with deterministic timing. Runs on anything from a small edge box up to a full DGX system.

If imaging is part of the picture an X-ray, an ultrasound MONAI and Clara give a validated path for that piece specifically. Pretrained models already built for the exact modality.

For the reasoning layer actually weighing symptoms against triage protocols Nemotron's healthcare-agent track is the closest fit. It's built for reasoning tasks like this, not general conversation.

None of these pieces do the whole job alone.

The interesting design work is in how they hand off to each other.

This is the part I think is easy to get backwards.

If you start from "what can the agent do" instead of "what should it be allowed to decide."

The current FDA guidance draws a useful line. A tool offering a single, clinically appropriate recommendation can move faster through regulation but only if a clinician can independently review the logic and data behind it. Nothing opaque. Nothing the human can't check.

The EU AI Act goes further. It classifies anything used to inform clinical decisions as high-risk by default, with mandatory human-oversight obligations attached.

Put those two things next to that 8–20% hallucination figure from earlier, and the design principle more or less writes itself.

It surfaces a recommendation. Shows its reasoning. Flags its own confidence level.

A person makes the actual call.

That's not a compliance box to check afterward. It has to be the starting constraint the whole architecture is built around retrofitting oversight onto a system designed to act autonomously is much harder than designing the handoff in from day one.

If I were sketching the first version, here's the question I'd keep coming back to:

Does the interface make it obvious, every single time, what the agent knows versus what it's guessing?

A confident-sounding wrong answer is far more dangerous here than an uncertain one. Uncertainty at least prompts a clinician to double-check.

That's a UI and interaction-design problem as much as a model problem. Maybe more.

That's today's exploration.

No build this week just the thinking that has to happen before anyone touches code on something like this.

Past issues are in the archive. See you tomorrow.

NVIDIA Clara for Medical Devices: The starting reference point for seeing how Holoscan, MONAI, and Isaac for Healthcare actually fit together on real hardware. Worth a slow read before any healthcare-agent project, build or not.

NVIDIA Healthcare Stack: NVIDIA Clara for Medical Devices Holoscan, MONAI, IGX, and Isaac for Healthcare explained together

Nemotron for Healthcare Agents: NVIDIA AI Platforms for Healthcare and Life Sciences - the direct source naming "ambient healthcare agents" as a target use case

Regulatory Reality: The Governance Gap in Clinical AI - FDA device counts and the 8–20% hallucination rate finding

2026 FDA Guidance Explained: FDA Loosens AI Oversight: What Clinicians Need to Know - the "glass box" standard and where FDA still holds the line

That’s it for today !☀

Edge AI is levelling up are you? Until next time, stay curious, stay building, and don’t let your machines take over. 🤖😆

Enjoyed today’s issue? Share OptimusEdge AI with your engineering team. Subscribe to OptimusEdge AI

Your Edge AI Explorer,
Sharat Sami (Let’s connect on LinkedIn)